Cargando…
Cryobiopsy for pneumonitis diagnosis in NSCLC immunotherapy
Nowadays immunotherapy is considered the tip of the arrow as treatment for non-small cell lung cancer for inoperable patients. Programmed death-ligand 1 is considered a valuable marker for the success of immunotherapy. The higher the score ≥50% the more successful the treatment will be. However; pre...
Autores principales: | Zarogoulidis, Paul, Kosmidis, Christoforos, Perdikouri, Eleni-Isidora, Hohemforst-Schmidt, Wolfgang, Sardeli, Chrisanthi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489498/ https://www.ncbi.nlm.nih.gov/pubmed/36161237 http://dx.doi.org/10.1016/j.rmcr.2022.101741 |
Ejemplares similares
-
Radial-EBUS: CryoBiopsy Versus Conventional Biopsy: Time-Sample and C-Arm
por: Zarogoulidis, Paul, et al.
Publicado: (2022) -
Modification of Apremilast from Pills to Aerosol a Future Concept
por: Zarogoulidis, Paul, et al.
Publicado: (2021) -
Non-Small-Cell Lung Cancer Immunotherapy and Sleep Characteristics: The Crossroad for Optimal Survival
por: Zarogoulidis, Paul, et al.
Publicado: (2023) -
Interventional bronchoscopy for HPV 16 and 66 with the use of spraying interferon-α (2b) plus bevacizumab and anti-reflux agent
por: Zarogoulidis, Paul, et al.
Publicado: (2021) -
Immunotherapy “Shock” with vitiligo due to nivolumab administration as third line therapy in lung adenocarcinoma
por: Zarogoulidis, Paul, et al.
Publicado: (2017)